|

Cyclophosphamide injection Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • Medical University of South Carolina1
  • Instituto Nacional de Cancer, Brazil1
  • Hebei Medical University Fourth Hospital1

Indications

  • Cancer3
  • Chronic Lymphocytic Leukemia1
  • Hodgkin Lymphoma1
  • Non-hodgkin Lymphoma1
  • B-Cell Non-Hodgkin Lymphoma1

Other2 trials

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Phase 2
PTCy and ATG for MSD and MUD Transplants
Phase 1/2

Charleston, South Carolina1 trial

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Hollings Cancer Center at Medical University of South Carolina

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.